mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.4 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.4 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
purmorphamine |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.4 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
avicin D |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.4 |
mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
-0.05 |
0.4 |
mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |